Diagnostics

Bupa Hong Kong has selected Cognizant to deliver an AI-driven BPaaS solution to transform health insurance claims

Strategic collaboration aims to enhance operational efficiency and mitigate risks by transitioning to a business process more aligned with regulatory…

6 hours ago

DiagnosTear Signs Non-Binding Term Sheet with Sheba Impact and Ramot to Exclusively License New Eye Imaging Technology, CLARIFY, Enabling Needle-Free Blood Count

Vancouver, British Columbia--(Newsfile Corp. - December 17, 2025) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"),…

12 hours ago

IDBS celebrates customer successes and product innovations in 2025

WOKING, United Kingdom, Dec. 17, 2025 /PRNewswire/ -- As 2025 draws to a close, IDBS celebrates customer successes and key…

18 hours ago

Ultromics Secures Strategic Investment from the American Heart Association’s Go Red for Women Venture Fund™

Funding accelerates Ultromics' work to close one of medicine's most pervasive health-equity gaps: heart failure with preserved ejection fraction (HFpEF),…

18 hours ago

Careverse Announces the First AI Operating System for All Care — Invites Providers to Become Founding Owners

WASHINGTON, Dec. 17, 2025 /PRNewswire/ -- Careverse announces the launch of the world's first AI Operating System for All Care,…

18 hours ago

Xtalks Releases 2025 Webinar Year-in-Review Showcasing Key Life Science Trends

TORONTO, Dec. 17, 2025 /PRNewswire/ -- Xtalks — The Life Science Community™, a leading B2B digital media platform serving the…

18 hours ago

Danaher Schedules Fourth Quarter 2025 Earnings Conference Call

WASHINGTON, Dec. 17, 2025 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call…

18 hours ago

Bioptimus Unveils M-Optimus, a World Model for Biology

Revolutionary model represents a transformative step toward AI-powered virtual tissues, patient digital twins, and a new era of data-driven biomedical…

18 hours ago

Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare

Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorporation.com PLAINVIEW,…

21 hours ago

Vaso Corporation Announces Fifth Extension of Sales Representation Agreement with GE HealthCare

Vaso Corporation137 Commercial StreetPlainview, New York 11803Tel: (516) 997-4600 Fax: (516) 997-2299 Investor Contact:Jonathan NewtonInvestor RelationsPhone: 516-997-4600 Email: jnewton@vasocorporation.com PLAINVIEW,…

21 hours ago